Critical appraisal:Von Rahden BH, Stein HJ, Weber A, Vieth M, Stolte M, Rösch T, et al 2008 3
From Cancer Guidelines Wiki
Critical Appraisal
Article being appraised
von Rahden BH, Stein HJ, Weber A, Vieth M, Stolte M, Rösch T, et al. Critical reappraisal of current surveillance strategies for Barrett's esophagus: analysis of a large German Barrett's database. Dis Esophagus 2008;21(8):685-9 Available from: http://www.ncbi.nlm.nih.gov/pubmed/18847456.
Applicable clinical question
Key Facts
Study Design
prevalence and incidence study
Number of Patients:
1438
Evidence ratings
Risk of bias
| High risk of bias | Comments: Please replace this text and include any additional comments in regards to your quality rating |
Result of appraisal
Included
Comments
Completed by
This appraisal has been completed.
- Article
- von Rahden BH, Stein HJ, Weber A, Vieth M, Stolte M, Rösch T, et al. Critical reappraisal of current surveillance strategies for Barrett's esophagus: analysis of a large German Barrett's database. Dis Esophagus 2008;21(8):685-9 Available from: http://www.ncbi.nlm.nih.gov/pubmed/18847456.
- Assigned to
- User:Freddy.sitas
- Topic area
- Guidelines:Barrett's
- Clinical question
Section below only relevant for Cancer Council Project Officer
Either HG-IN or Ca (‘malignant BE’) was detected in altogether 28 cases (1.9%) during a median follow-up of 24 months (range 1–255), accounting for an incidence
of 0.95% per year of follow-up. Analysis per group revealed a significantly higher incidence (P < 0.001, c2-test) of HG-IN/Ca in the LG-IN group (n = 11, 19.3%) compared with the group of patients with non-neoplastic BE (n = 17, 1.2%; see Table 2).